News for Nordic Nanovector ASA (8NN.F)

Published at

Feb 18, 2021 7:32 AM

by prnewswire.com

mixed

mixed

Nordic Nanovector ASA: Results for the Fourth Quarter and Full Year 2020

/PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) announces its results for the fourth quarter and full year 2020. A live webcast presentation by Nordic...

NANOV.OL NANO.OL NANOVO.OL 8NN.SG 8NN.F

Read more →
Published at

Feb 18, 2021 7:07 AM

by prnewswire.com

neutral

neutral

Nordic Nanovector Sees Significant Improvement in Patient Recruitment Rate in PARADIGME, its Single-arm Phase 2 Pivotal Trial with Betalutin® in R/R Follicular Lymphoma

/PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) provides an update on PARADIGME, its ongoing pivotal Phase 2b trial of Betalutin® (177Lu lilotomab...

8NN.SG 8NN.F

Read more →
Published at

Feb 15, 2021 6:19 PM

by thestreet.com

neutral

neutral

Nordic Nanovector ASA: Invitation To Fourth Quarter And Full Year 2020 Results Presentation And Webcast

OSLO, Norway, Feb. 15, 2021 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) announces that it will report its results for the fourth quarter and full year

NANOV.OL NANO.OL 8NN.SG 8NN.F

Read more →
Published at

Feb 15, 2021 6:19 PM

by prnewswire.com

mixed

mixed

Nordic Nanovector ASA: Invitation to Fourth Quarter and Full Year 2020 Results Presentation and Webcast

/PRNewswire/ -- Nordic Nanovector ASA (OSE: NANOV) announces that it will report its results for the fourth quarter and full year 2020 on Thursday, 18 February...

NANOV.OL NANO.OL 8NN.SG 8NN.F

Read more →

News for Nordic Nanovector ASA (8NN.F)

Nordic Nanovector ASA: Results for the Fourth Quarter and Full Year 2020

Nordic Nanovector Sees Significant Improvement in Patient Recruitment Rate in PARADIGME, its Single-arm Phase 2 Pivotal Trial with Betalutin® in R/R Follicular Lymphoma

Nordic Nanovector ASA: Invitation To Fourth Quarter And Full Year 2020 Results Presentation And Webcast

Nordic Nanovector ASA: Invitation to Fourth Quarter and Full Year 2020 Results Presentation and Webcast